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Abstract
Background: The population of adolescents and young adults with congenital heart disease (CHD) is growing
exponentially. These survivors are at risk of late cardiac complications and require lifelong cardiology care. However,
there is a paucity of data on how to prepare adolescents to assume responsibility for their health and function
within the adult health care system. Evidence-based transition strategies are required.
Methods: The Congenital Heart Adolescents Participating in Transition Evaluation Research (CHAPTER 2) Study is a
two-site cluster randomized clinical trial designed to evaluate the efficacy of a nurse-led transition intervention for
16–17 year olds with moderate or complex CHD. The primary endpoint is excess time to adult CHD care, defined as
the time interval between the final pediatric cardiology appointment and the first adult CHD appointment, minus
the recommended time interval between these appointments. Secondary endpoints include the MyHeart score
(CHD knowledge), Transition Readiness Assessment Questionnaire score, and need for catheter or surgical
re-intervention. Participants are enrolled in clusters based on week of attendance in the pediatric cardiology clinic.
The intervention consists of two one-hour individualized sessions between a cardiology nurse and study participant.
Session One focuses on knowledge of the participant’s CHD, review of their cardiac anatomy and prior
interventions, and potential late cardiac complications. Session Two focuses on self-management and
communication skills through review and discussion of videos and role-play. The study will recruit 120 participants.
Discussion: Many adolescents and young adults experience a gap in care predisposing them to late cardiac
complications. The CHAPTER 2 Study will investigate the impact of a nurse-led transition intervention among
adolescents with CHD. Fidelity of the intervention is a major focus and priority. This study will build on our
experience by (i) enrolling at two tertiary care programs, (ii) including a self-management intervention component,
and (iii) evaluating the impact of the intervention on time to ACHD care, a clinically relevant outcome. The results
of this study will inform pediatric cardiology programs, patients and policy makers in judging whether a structured
intervention program provides clinically meaningful outcomes for adolescents and young adults living with CHD.
Trial registration: ClinicalTrials.gov ID NCT01723332
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Background
Major advances in the management of children with
congenital heart disease (CHD) have evolved over the
past three decades. As a consequence, over 90 % of these
children reach adulthood and the population of adoles-
cents and young adults with CHD is growing exponen-
tially [1].However, this emerging “survivor” population
has complex needs. These individuals are at risk of sub-
stantial cardiac morbidity [2, 3] and mortality [4, 5] in
early-to-mid adult years. Unfortunately, 14–53 % of
young adults are not successfully transferred to an adult
CHD (ACHD) centre after graduating from a pediatric
cardiac centre [6–8], and failure to attend an ACHD
clinic results in excess cardiac morbidity [7, 9, 10]. Fur-
thermore, adolescents and young adults with CHD have
limited knowledge about their heart [11–13], limiting
their ability to communicate confidently with health care
providers [14].
At present there is a paucity of outcome data regard-
ing the impact and effectiveness of CHD transition inter-
ventions. Indeed, there is a lack of transition outcome
data for chronic pediatric conditions in general. This
speaks to the urgency of developing evidence-based
intervention programs that will optimize pediatric to
adult health care transition using methods that can be
readily adopted by clinical programs. The American Heart
Association published a Scientific Statement on the sub-
ject of transition in 2011 that emphasized the relevance of
this topic to the CHD community and acknowledged the
lack of data on transition programming [15].
To address these knowledge gaps our team conducted
the Congenital Heart Adolescents Participating in Tran-
sition Evaluation Research (CHAPTER 1) Study [16] to
evaluate a single-session nurse-led transition education
intervention, focusing on CHD knowledge, for youth
15–17 years of age. This study significantly improved pa-
tients’ knowledge of their CHD lesion in the interven-
tion group at one month, which was sustained at
6 months. The intervention group also had higher self-
management skills at six months, even though self-
management skills were not the focus of the intervention.
Limitations of this study include enrollment at a single
center and use of surrogate outcomes (questionnaires) ra-
ther than participant behaviors such as attendance at an
ACHD clinic. The current study was designed to build
upon our experience with CHAPTER 1, specifically to in-
clude a self-management component of the intervention,
to document time to first ACHD clinic appointment, and
to assess generalizability of the intervention across more
than one clinical program.
The primary aim of the CHAPTER 2 study is to deter-
mine the impact of a nurse-led intervention on time to
first ACHD clinic attendance among youth graduating
from one of two quaternary-care pediatric cardiology
programs. We hypothesize that the transition interven-
tion in combination with usual care will result in super-
ior timing of the first ACHD clinic attendance compared
to usual care alone. Secondary aims are to describe: 1)
change in adolescent knowledge of their CHD, 2) change
in self-management and self-advocacy skills using vali-
dated instruments [17, 18], 3) Incidence of cardiac pro-
cedures post enrollment, and 4) the frequency and
content of verbal and written (email/text messaging) dia-
logue between nurse and participant.
Methods
Study design
The CHAPTER 2 Study is a two-center cluster random-
ized controlled trial of a nurse-led transition interven-
tion versus usual care (see “usual care” section below).
The intervention will consist of two individualized ses-
sions lasting ~60 min each held two months apart, in or
adjacent to the pediatric cardiology clinic. The study is
registered with Clinical Trials.gov (ID NCT01723332)
and will be conducted in accordance with CONSORT
guidelines (Fig. 1) [19].
Study setting and participants
The study will be conducted at The Hospital for Sick
Children (“SickKids”, Toronto, Canada) and the Stollery
Children’s Hospital (Edmonton, Canada). These are the
largest pediatric cardiology programs in Canada and
offer the full range of cardiology and cardiac surgical
subspecialty services. We will include 16–17 year olds
with moderate or complex CHD (as previously defined)
[20] who have not yet been transferred to adult care. Ex-
clusion criteria will be (i) less than a Grade 6 level of
reading and comprehension, based on parent report, and
(ii) heart transplantation.
Transition intervention
The intervention will be conducted by one of two cardi-
ology registered nurses (RNs) at each site (total 4 RNs)
who are experienced working with teens. Youth will at-
tend two one-on-one sessions with the same RN. Ses-
sions will be youth-oriented, interactive, and engaging.
Session One will occur immediately after a pediatric car-
diology clinic visit to minimize study burden and to ad-
here with recommendations that transition interventions
be delivered in clinical settings [21]. Individual sessions,
in contrast to group sessions, allow the content to be
patient-specific. Session Two will occur two months after
Session One, in conjunction with another clinic appoint-
ment or as the sole purpose of a return visit. Individual
participant flow through the study is illustrated in Fig. 2.
Immediately prior to Session One, the RN will review
the cardiology chart to become familiar with the cardiac
history including CHD diagnoses, names and dates of
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cardiac surgical procedures and cardiac catheterizations,
and current cardiac medications and doses. Session One
(1 h) will emphasize education; Session Two (1.0–1.5 h)
will emphasize self-management. Details of each session
are summarized in Table 1.
Treatment fidelity and quality assurance
Consistency of the intervention between study RNs
and study participants is a priority of this study.
Team education will start with an in-person two-day
meeting in Toronto involving study RNs, led by the
study investigator (GRR) who co-developed and
conducted many of the interventions in the CHAP-
TER 1 study [16]. Professionally filmed video-tapes
depicting Sessions One and Two were prepared for
the RNs on how to conduct the sessions with a
standardized patient. These teaching videos will be
viewed by each study RN and role-playing will be
performed for practice.
Audio recordings of sessions One and Two with study
participants will be conducted if the participant agrees.
Evaluation of treatment fidelity will be based on review
of nursing logs and/or audiotapes by other study RNs
and team members (ASM, GRR). Monthly conference
calls involving all study RNs will be conducted to pro-
vide feedback and discuss issues related to the interven-
tion as they arise.
After each session the RN will complete an interven-
tion log. The RN will record completion of each inter-
vention component as described in Table 1, and use field
notes to record the participant’s knowledge, enthusiasm,
and commitment to the intervention. All intervention
logs and field notes will be reviewed monthly by team
members (ASM, GRR, and RNs), as part of ongoing
quality assurance.
Analyzed (n ~ 60)
Excluded from analysis (n = 0; Intention-to-
treat analysis) 
1 Month Questionnaires
6 Month Questionnaires 
12 Month Chart Review
12 Month Questionnaires
18 Month Questionnaires
24 Month Chart Review
Discontinued intervention (give reasons) 
1 Month Questionnaires
6 Month Questionnaires
12 Month Chart Review
12 Month Questionnaires
18 Month Questionnaires
24 Month Chart Review
Analyzed (n ~ 60)
Excluded from analysis (n = 0; Intention-to-
treat analysis)
See Text
Allocated to Transition Intervention
(n ~ 60)
Received allocated intervention
Did not receive allocated intervention 
(give reasons)
Allocated to Usual Care
(n ~ 60)
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Usual care
No transition program is formally in place at the
Stollery site. Families receive written information
about their child’s CHD, suggested timelines for
increasing teens’ self-management of his/her CHD,
and at the last pediatric visit a “graduation” package
with information about the ACHD program is
provided. At SickKids, usual care is similar. However,
to account for potential differences in usual care,
randomization will be stratified by site. With multiple
pediatric cardiologists and clinic nurses at each site,
clinician-led education is likely variable and con-
strained by limited clinic time. At both sites, pertin-
ent medical records are sent to ACHD providers at
the time of transfer. Both ACHD clinics send a wel-
come letter to patients indicating approximately when
their first ACHD appointment will be. A second letter
is sent one month prior to the first ACHD appoint-
ment with the date and time. Patients who do not
attend are contacted by telephone to reschedule. All
components of usual care will be tracked by the
project coordinator at each site, and any change in
usual care during the study will be documented.
Group allocation
Participants will be randomized by clusters defined by
week of attendance in the pediatric cardiology clinic. As
week (not study participant) is the unit of randomization,
this is a cluster randomization design. This method of
randomization: 1) prevents two adolescents in the same
waiting room being allocated to different groups and 2)
facilitates scheduling of study RNs, who will be avail-
able at short notice to provide the intervention during
intervention weeks. Cardiologists will not be informed
of group assignment, preventing potential bias by
cardiologist co-intervention. We anticipate enrollment
of 3–4 patients per week, i.e., cluster size will be ≤ 4. To
determine which weeks are “intervention weeks” vs.
“usual care weeks”, a biostatistician will prepare a
randomization sequence.
A 1:1 ratio of intervention: usual care weeks will be
used until midway through enrollment, when there will
be a re-evaluation. If there is an imbalance, then there
will be an adjustment of the ratio of intervention to
usual care weeks.
Protecting against sources of bias
Participants, their parents, and the study RNs will be
aware of group allocation as blinding is not feasible.
However, clinical outcomes will be adjudicated by ob-
servers who are blind to group allocation (see Secondary
outcomes #4 below). Furthermore, participants in both
groups will be unaware of the primary outcome (excess
time to attendance at first ACHD appointment) and
therefore this outcome cannot be consciously influenced,
though participants will be aware that the study will
track information from the cardiology chart, including
the first ACHD clinic visit. Clinic support staff and
pediatric cardiologists will be blind to group allocation.
Outcome measures
Outcome measures correspond to aims as described
above. The primary outcome will be the excess time be-
tween pediatric and ACHD care, defined as the time
interval (in months) between the final pediatric visit and
the first ACHD visit, minus the recommended time
interval between these visits. The “recommended time”
interval will be the interval suggested by the cardiologist
Fig. 2 Individual participant timeline
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at the final pediatric visit. For example, if the time be-
tween the final pediatric visit and first ACHD visit was
20 months but the pediatric cardiologist recommended
this be 12 months, the excess time would be 8 months.
If the first ACHD visit takes place before the recom-
mended time, the excess time will be zero. For the rare
study participant not having a documented “recom-
mended time”, recommendations for frequency of care
will be taken from published guidelines [22, 23]. Excess
time to ACHD care is an objective and clinically mean-
ingful outcome, as lapses between pediatric and ACHD
care result in increased cardiac morbidity and need for
re-intervention [9]. First ACHD appointments that occur
2 or more months later than had been recommended by
the referring pediatric cardiologist will result in a review
of medical records to identify potential participant or
system factors, including a) ACHD waiting list too long
to accommodate participant when recommended, b)
ACHD team unaware of initial referral, or c) participant
did not agree to an earlier appointment.
Secondary outcomes
Given the complex, multidimensional nature of the transi-
tion process, transition interventions need to consider
multiple outcomes, including cognitive factors (e.g. CHD
knowledge) and self-management behaviours. Therefore,
Table 1 Transition Intervention: summary of characteristics and content
Characteristic Session 1: Emphasis on Education
(Held at time of enrollment)
Session 2: Emphasis on Self-management
(2 months post Session 1)
Aim To inform participants about their heart condition To motivate participants to self-manage and selfadvocate
Approach Didactic/educational Experiential/engaging




Content a) Introduction to transition/its importance a) Discuss education-related goal set in Session 1
b) Discussion of confidentiality, promote trust with RN b) Discussion of “self-management” and its relevance
to health
c) Creation of MyHealth passport, including c) View & discuss six 1-min videos illustrating interactions
between a health care provider (HCP) & young adults with
poor vs. strong assertiveness skills- name of cardiac condition
- previous cardiac interventions
- name and purpose of medications
d) Review cardiac anatomy (patient-specific) d) View & discuss “Talking with your doctor” video;
review GLADD approach (Give, Listen, Ask, Decide, Do)
e) Discussion of potential future cardiac complications
(patient-specific)
e) Role-play an interaction between a HCP & the
participant who practices being assertive
f) Review names & location of local ACHD cardiologists f) Discuss SMART goal setting (Specific, Measurable,
Attainable, Realistic, Timely)
g) Introduction to relevant websites g) Review booklet “When You’re 18”, take home
h) Discussion of 3 scenarios addressing alcohol,
smoking/street drugs, & sexuality/contraception
h) Visit website “Health Care Transitions”
i) Introduce youth-oriented take-home written materials i) Encourage email or text messages with RN. Questions
posed within 7 days:
1. “What helped you the most?”
2. “What helped you the least?”
3. “Do you have any questions for me?”
j) Set one education-related goal for session 2
k) Accompany participant to the ACHD clinic
l) Provide study email address; encourage emails or text
messages with RN. Questions posed to participants within 7 days:
1. “Where is your MyHealth passport now?”
2. “Have you used your MyHealth passport or shown it to
anyone?”
3. “Do you have any questions for me?”
ACHD adult congenital heart disease; RN: registered nurse
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several secondary outcomes are proposed. All baseline
questionnaires will be completed in the pediatric clinic,
and prior to Session One for those in the intervention arm.
1) Change in MyHeart scores between baseline, 1, 6, 12
and 18 months. The MyHeart scale consists of eight
questions that assess participant’s knowledge of their
cardiac condition. The MyHeart scale was developed
for the CHAPTER 1 study, with a significant
improvement in score observed at 1 and 6 months
post intervention, compared to participants in the
usual care group [16].
2) Change in Transition Readiness Assessment
Questionnaire (TRAQ) score between baseline, 1, 6,
12, and 18 months. The TRAQ is the most rigorous
transition readiness scale for adolescents. Sawicki et
al. identified behaviours relevant to transition, tested
item reliability and validity, and then field tested the
items with 194 youth with special healthcare needs
[18]. Scores range from 0 to 5. Principal component
factor analysis revealed two domains explaining 68 %
of the total variance: self-management (16 items,
mean score 3.01 ± 1.02) assessing skills such as filling
prescriptions,
understanding treatment side effects, and arranging
medical follow-up visits; and self-advocacy (13 items,
mean score 3.67 ± 0.77) assessing communication
skills with the healthcare team, managing activities
of daily living, and use of school and community
resources. Internal consistency is high, with
Cronbach’s alpha of 0.92 (Self-management) and
0.82 (Self-advocacy). A ceiling effect is unlikely given
the mean scores noted above. The reading level is
Grade 5.7 and this instrument takes ~5 min to
complete. The 12 and 18 month assessments will
provide longitudinal data on evolution of self-
management and self-advocacy skills and will allow
participants in the intervention group sufficient time
to apply the skills gained (e.g., to independently book
a physician appointment).
3) Change in the Williams’ Scale between baseline, 1, 6,
12, and 18 months. The Williams’ scale is a measure
of medical self-management and transition readiness
among adolescents with special health care needs,
having high internal consistency (Cronbach’s alpha
0.89) [17]. This consists of 21 Likert-scaled items
and has a grade 4.9 reading level.
4) Assessment of patient engagement via a cardiologist
questionnaire. This questionnaire will be completed
by the participant’s primary cardiologist at the first
cardiology clinic visit (pediatric or adult site), after
month 3 post enrollment. This questionnaire will
help determine if those participants in the intervention
group were more engaged with their cardiologist then
those in the usual care group. The single-page
questionnaire consists of six items and takes 1–2 min
to complete.
5) Incidence of cardiac re-intervention (surgery or
interventional catheterization). Chart review at 12
and 24 months post enrollment will be done
independently by two RNs who will be blinded to
group allocation. This review will ascertain cardiac
hospitalizations and invasive cardiac procedures
(since study enrollment), confirm attendance at
ACHD clinic, and identify new or progressive
complications (e.g., endocarditis, heart failure,
stroke, thrombosis, systemic or pulmonary emboli,
arrhythmia requiring drug or procedural
intervention, renal or hepatic failure) [2].
Discrepant adjudication will be resolved by a
cardiologist team member.
6) Frequency and content of verbal and written (email/
text messaging/telephone) dialogue between
intervention nurse and participant. The intervention
RN will complete detailed post-intervention field
notes after each session. Telephone communication
(phone calls, text messages) and emails will be
encouraged from participants at any time; all will be
recorded verbatim and analyzed (see Quantitative
data analysis below).
Measurement of outcomes at follow-up
Documentation of first ACHD visit will be done at 12
and 24 month chart review and will include potential
barriers to ACHD clinic attendance. Regarding sec-
ondary outcomes 1–3, participants will complete the
follow-up questionnaires at home, independent of their
parent(s). Adolescents not completing the follow-up
questionnaires will be contacted by mail, email, or text
(depending on their preference) every two weeks for a
total of three times, and then telephoned once, to be
reminded. A $25 gift certificate will be provided to
participants at each of the 1, 6, 12, and 18 month time
points to acknowledge their time and commitment to
questionnaire completion.
Proposed sample size
The sample size is based on testing group differences in
the primary outcome, excess time to ACHD care, with a
two-sided log-rank test. A sample size of 60 patients per
group (120 total) will allow detection of a difference be-
tween 90 and 70 %, the proportions that have attended
their first ACHD clinic appointment by the end of the
observation period in the intervention and usual care
groups, respectively, with 80 + % power (Type I Error
Probability [α] = 0.05), accounting for the “design effect”
due to the cluster randomization of the trial. The
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proportion of 70 % in the usual care group is conserva-
tive, as published SickKids data suggests it may be as
low as 50 % [8]. If the proportion of usual care partici-
pants attending the ACHD clinic is <70 %, the study
power will be even higher. The difference between 90
and 70 % is the minimum clinically important difference,
as a proportion <90 % attending ACHD care is un-
acceptably low [15]. Given that the most common
reason for a lapse in care prior to first ACHD visit is a
belief that cardiac follow-up is not required [9], a mis-
conception that the intervention will address, we believe
that a 90 % ACHD clinic attendance in the intervention
group is achievable.
Quantitative data analysis
Intention-to-treat analysis will be used and all statistical
tests will be two-sided. Baseline characteristics of the
control (usual care) and intervention groups will be
summarized using descriptive statistics (e.g., means, me-
dians, standard deviations, frequencies, proportions).
Kaplan-Meier plots will display excess time to first
ACHD appointment by treatment group. Log-rank tests
with a cluster-level bootstrap will test the difference in
the excess time distribution between the intervention
and control groups. The cluster sizes are likely to be 3–
4. All statistical analyses will account for the cluster
randomization. Participants who have not attended the
ACHD clinic by the end of the study period (i.e., are
censored) will still contribute to the primary outcome,
as survival analysis is designed to accommodate cen-
sored data. We will assess differences in mean scores of
each secondary outcome at baseline, 1, 6, 12, and
18 months, where applicable, by treatment group using
general linear mixed models [24] that take both the clus-
ter randomization and longitudinal nature of the data
into account. Additional analyses will be stratified by a)
study site (Edmonton versus Toronto) and b) attended
first ACHD appointment (yes/no).
Qualitative data analysis
All field notes and text/email messages between the RN
and participant will be saved, anonymized, and analyzed
for codes, categories and subcategories as per qualitative
deductive content analysis [25–27]. Data will be analyzed
for manifest and latent content, latent content referring
to the time that passes between each text message (or
email), the word and sentence formations, and the
(in)formality and use of language.
Discussion
The rapidly growing population of adolescent and young
adult survivors of CHD is at risk of late cardiac and
non-cardiac morbidity and premature mortality. Numer-
ous barriers exist to delivering specialized ACHD care to
this population, including a lack of ACHD providers in
many developed countries [28, 29]. Unfortunately, few
pediatric cardiology programs facilitate the transition of
adolescents in their care [30], and many adolescents and
young adults experience a gap in care [7, 8, 31] predis-
posing them to late cardiac complications [9]. To our
knowledge, the single-centre CHAPTER 1 study is the
only published controlled clinical trial of a transition
intervention in the CHD population. The CHAPTER 2
study will build on our experience by (i) enrolling at two
tertiary care programs, (ii) including a self-management
intervention component, and (iii) evaluating the impact
of the intervention on time to ACHD care, a clinically
relevant outcome.
Potential limitations
Several threats to internal validity exist. These include:
(i) co-intervention; awareness of the study and of the
need for health care transition may influence what cardi-
ologists say to participants, however both groups will
benefit equally and this will not create a bias towards
one study group. Cardiologists will be unaware of group
allocation. (ii) Loss to follow-up; when patients miss ap-
pointments, both Edmonton and Toronto ACHD clinics
routinely use all available contact information to arrange
another appointment and keep patients in care. From
the perspective of the study, participants who have not
attended the ACHD clinic by the end of the study period
will be censored and will still contribute to the primary
outcome. (iii) Provider/system factors such as waiting
lists may influence the primary outcome. However this
will be equally true of participants in both groups. The
time interval between the recommended date of first
ACHD appointment and scheduled date of first ACHD
appointment will be recorded to capture provider/sys-
tem factors. The mean wait time for non-urgent referrals
to Canadian ACHD clinics is only 4 ± 2 months [29], so
we do not anticipate this to be an issue. (iv) Responsive-
ness of the Williams’ transition readiness scale to inter-
vention is not yet known, though this is just one of six
secondary endpoints. Both the TRAQ and MyHeart
scale are responsive to an educational intervention [16].
In summary, the CHAPTER 2 study is a two-center
cluster randomized clinical trial of a nurse led transition
intervention for 16–17 year olds with moderate or
complex CHD. Fidelity of the intervention is a major
focus and priority. We will evaluate time to first ACHD
appointment, CHD knowledge, transition readiness,
need for catheter and surgical re-intervention, and
qualitative outcomes. The results of this study will
inform pediatric cardiology programs, patients and pol-
icy makers in judging whether a structured intervention
program provides clinically meaningful outcomes for
adolescents and young adults living with CHD.
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